Nonprofit · EIN 51-0306704
CLAYTON MEDICAL RESEARCH FOUNDATION INC
Tax-exempt · CARSON CITY, NV 89703
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $5,236,838 | $3,126,466 | $2,110,372 | $100,006,501 | $2,464,588 | $97,541,913 |
| December 31, 2023 | 990 | $2,839,778 | $3,913,882 | -$1,074,104 | $88,853,594 | $2,904,230 | $85,949,364 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $0
- Program service revenue
- $0
- Investment income
- $5,236,838
- Net gain from sales of assets
- $2,876,344
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $2,538,781
- Compensation of officers, directors and key employees
- $71,415
- Salaries, compensation and benefits (total)
- $264,877
- Professional fundraising fees
- $0
- Legal fees
- $8,868
- Accounting fees
- $14,000
- Occupancy
- $21,000
- Travel
- $1,269
- Program services (functional)
- $2,804,343
- Management and general (functional)
- $322,123
Balance sheet and other
- Total assets, start of year
- $88,853,594
- Total assets, end of year
- $100,006,501
- Total liabilities, end of year
- $2,464,588
- Net assets, end of year
- $97,541,913
- Publicly traded securities
- $99,527,745
- Net assets without donor restrictions
- $84,337,298
- Net assets with donor restrictions
- $13,204,615
- Gross receipts
- $10,421,219
- Employees
- 0
- Year formed
- 1989
- State of legal domicile
- DE
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| Robert M Wallace | Trustee, President Trustee or director, Officer | 8 | $14,283 | $671,732 | $99,413 |
| Jarred W Sloan | Trustee, Vice President, Treasurer Trustee or director, Officer | 6 | $14,283 | $671,732 | $99,413 |
| Lynn P Carter | Trustee Trustee or director | 4 | $14,283 | $671,732 | $99,413 |
| Joan S Dunlap | Trustee,VP,Assistant Secretary Trustee or director, Officer | 4 | $14,283 | $603,462 | $89,294 |
| Brian W Crozier | Trustee, Chairman Trustee or director, Officer | 2 | $14,283 | $342,765 | $49,850 |
| Robert L Evans | VP, Assistant Treasurer Officer | 0 | $0 | $222,000 | $83,150 |
| John Russell Beekman | Vice President Officer | 10 | $0 | $117,543 | $40,505 |
| Christopher MacKenzie | Vice President, Secretary Officer | 1 | $0 | $0 | $0 |
990 for the year ended December 31, 2023: 9 people
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| Robert M Wallace | Trustee, President Trustee or director, Officer | 8 | $13,813 | $649,643 | $97,800 |
| Jarred W Sloan | Trustee, Vice President, Treasurer Trustee or director, Officer | 6 | $13,813 | $649,643 | $97,800 |
| Lynn P Carter | Trustee Trustee or director | 4 | $13,813 | $649,643 | $97,800 |
| Joan S Dunlap | Trustee,VP,Assistant Secretary Trustee or director, Officer | 4 | $9,920 | $490,166 | $88,019 |
| Brian W Crozier | Trustee, Chairman Trustee or director, Officer | 2 | $13,813 | $331,493 | $50,086 |
| Thomas J Brorby Deceased | Trustee, Chairman Trustee or director, Officer | 2 | $11,479 | $275,483 | $16,600 |
| Robert L Evans | VP, Assistant Treasurer Officer | 0 | $0 | $210,000 | $81,846 |
| John Russell Beekman | Vice President Officer | 10 | $0 | $113,678 | $39,925 |
| Christopher MacKenzie | Vice President, Secretary Officer | 1 | $0 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 402 N DIVISION ST, CARSON CITY, NV 89703-4168
- Principal officer (990 for 2024)
- Robert M Wallace, 402 North Division St, Carson City, NV 89703
- Signed the 990
- Jarred W Sloan, Vice President & Treasurer
- Phone
- (775) 329-3111
Mission
As a supporting organization to the Clayton Foundation for Research (Clayton) the Foundation's primary mission is to fund medical research for the purpose of discovering the cause, prevention and cure of diseases for the benefit of mankind. The secondary mission is to transfer the resulting medical research discoveries from the laboratory to the use of the general public by patenting and licensing such technology for development into drugs or other products for the use and benefit of mankind through Clayton's other supporting entities.
Program accomplishments
- The Tumor Targeting Toxins grant to the University of California, San Diego, funds research directed to the discovery and development of compounds for cancer therapy, compounds synthesized with proteins joined by a sortase reaction, and compounds with cancer stem cell and hormone targeting ligands coupled with toxins for delivery to ovarian tumors and other epithelial tumors. Patent applications have been filed for these technologies by Research Development Foundation (RDF), a tax-exempt supporting organization of the Foundation see (Schedule R, Part III), and collaborations have been and are being established with other scientists and with commercial entities and consultants for manufacturing and development of drugs for human cancer indications.Expenses $943,073 · grants $852,781
- The Novel Biologically Active Peptides and Small Proteins grant to the Salk Institute for Biological Studies funds research. The overreaching hypothesis of this project is that novel drug targets exist among the thousands of newly discovered microproteins. The list includes uncharacterized secreted bioactive peptides and small proteins. In the past two years the focus has shifted from intracellular microproteins to uncharacterized secreted bioactive peptides because they are similar to peptide hormones and neuropeptides, which have proven expellant drug targets. Consequently, this project has three aims: the deep characterization of C4ORF48 in neurobiology and Alzheimer's disease (Aim 1), the role of augurin in metabolic health and cancer (Aim 2), and the continued identification of novel peptides to feed into this pipeline (Aim 3). As part of these broader efforts, tools have been developed for this project, such as ShortStop, to find and characterize these novel bioactive peptides.Expenses $578,912 · grants $525,800
- The MorfVeuss Discovery, Screening and Therapeutic Platform grant to the Salk Institute for Biological Studies funds research to develop a screening platform, called MorfVeuss, that will allow the discovery of micro-peptide drug targets while transforming these discoveries into gene and oncolytic viral therapeutic candidates. The objective of this platform is to overcome a critical unmet need in identifying and characterizing a novel class of therapeutics, building from very recent discoveries in the past decade in the emerging field of micro-proteins. Development of this platform should open the door for new breakthroughs and a pipeline of innovative new drug candidates, applicable across different indications.Expenses $496,021 · grants $448,220
- The Foundation funded 2 other medical research grants and project administration expenses at The Salk Institute for Biological Studies. The titles of the 2 additional grants are as follows: (1) Identification of functional markers for developing side effect-free non-opioid analgesicsExpenses $438,130 · grants $395,640
- (2) Bifunctional Small Molecules for Rapid Protein Clearance from BloodExpenses $348,207 · grants $316,340
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 51-0306704
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Supporting organization (509(a)(3))
- Donations deductible (Pub 78)
- Supporting organization of unknown type
- Exempt since
- 1988
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Assets (IRS master file)
- $100,006,501
- Income (IRS master file)
- $10,421,219
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $5,236,838 | $3,126,466 | $100,006,501 | IRS |
| 990 | December 2023 | $2,839,778 | $3,913,882 | $88,853,594 | XML |
| 990 | December 2022 | $2,968,221 | $2,947,932 | $77,997,012 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 51-0306704).
Questions about CLAYTON MEDICAL RESEARCH FOUNDATION INC
- What is the EIN of CLAYTON MEDICAL RESEARCH FOUNDATION INC?
- The employer identification number (EIN) of CLAYTON MEDICAL RESEARCH FOUNDATION INC is 51-0306704.
- Is CLAYTON MEDICAL RESEARCH FOUNDATION INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1988.
- Are donations to CLAYTON MEDICAL RESEARCH FOUNDATION INC tax-deductible?
- Yes. It is listed in IRS Publication 78 (Supporting organization of unknown type).
- Which annual return does CLAYTON MEDICAL RESEARCH FOUNDATION INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of CLAYTON MEDICAL RESEARCH FOUNDATION INC due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did CLAYTON MEDICAL RESEARCH FOUNDATION INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of CLAYTON MEDICAL RESEARCH FOUNDATION INC?
- The 990 for the year ended December 31, 2024 names Robert M Wallace.
- Who are the officers and directors of CLAYTON MEDICAL RESEARCH FOUNDATION INC?
- The 990 for the year ended December 31, 2024 lists 8 people; 5 received compensation from the organization, the highest $14,283 (Robert M Wallace, Trustee, President).
- How much revenue does CLAYTON MEDICAL RESEARCH FOUNDATION INC have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $5,236,838, expenses of $3,126,466 and total assets of $100,006,501 at year end.
Other nonprofits in CARSON CITY
- CARSON TAHOE REGIONAL HEALTHCARE EIN 88-0502320 · last filed 990 for 2024
- GREATER NEVADA CREDIT UNION EIN 88-0063808 · last filed 990 for 2024
- NEVADA HEALTH CENTERS INC EIN 94-3199117 · last filed 990 for 2025
- BOYS AND GIRLS CLUBS OF WESTERN NEVADA EIN 88-0269139 · last filed 990 for 2024
- CARSON CITY COMMUNITY COUNSELING CENTER EIN 88-0212354 · last filed 990 for 2023
- NEVADA BATTLE BORN GROWTH ESCALATOR INC EIN 81-4124846 · last filed 990 for 2025
- FOUNDATION FOR RESEARCH EIN 88-0234196 · last filed 990 for 2024
- RESEARCH DEVELOPMENT FOUNDATION EIN 88-0234325 · last filed 990 for 2024